Wells Fargo Sees Accelerating Market for HeartFlow as CT-Based Cardiac Testing Expands
Wells Fargo began coverage of HeartFlow with an Overweight rating, citing a structural shift toward coronary CT angiography (CCTA) that should lift demand for the company’s CT-based blood-flow and plaque analysis tools. The bank projects significant volume growth in CCTA and forecasts HeartFlow revenue rising more than 20% annually over the next th…